Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Moertel

Showing results (141-150 of 251) with videos related to

Pageof 26
Sort By:
Cancer Treatment Reports|February 1, 1980
Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinomaM J O'Connell, C G Moertel, J Rubin, et al.
American Journal of Clinical Oncology|October 1, 1984
A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancerJ Rubin, A J Schutt, M J O'Connell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacology of amygdalin (laetrile) in cancer patientsM M Ames, T P Moyer, J S Kovach, et al.
Cancer|September 15, 1984
Primary liver cancer. An Eastern Cooperative Oncology Group TrialG Falkson, J M MacIntyre, C G Moertel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomasC G Moertel, J Rubin, M J O'Connell, et al.
Cancer Treatment Reports|March 1, 1987
Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancerM J O'Connell, J Rubin, R G Hahn, et al.
Cancer Research|January 1, 1990
Phase I and clinical pharmacological evaluation of a parenteral hexamethylmelamine formulationM M Ames, R L Richardson, J S Kovach, et al.
Cancer Chemotherapy Reports|May 1, 1975
Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinomaC G Moertel, A J Schutt, R G Hahn, et al.
Cancer Chemotherapy Reports|July 1, 1975
Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinomaT A Marciniak, C G Moertel, A J Schutt, et al.
Cancer|August 1, 1986
The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancerC G Moertel, J R O'Fallon, V L Go, et al.
Pageof 26

Showing results (141-150 of 251) with videos related to

Sort By:
Pageof 26
Cancer Treatment Reports|February 1, 1980
Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinomaM J O'Connell, C G Moertel, J Rubin, et al.
American Journal of Clinical Oncology|October 1, 1984
A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancerJ Rubin, A J Schutt, M J O'Connell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacology of amygdalin (laetrile) in cancer patientsM M Ames, T P Moyer, J S Kovach, et al.
Cancer|September 15, 1984
Primary liver cancer. An Eastern Cooperative Oncology Group TrialG Falkson, J M MacIntyre, C G Moertel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomasC G Moertel, J Rubin, M J O'Connell, et al.
Cancer Treatment Reports|March 1, 1987
Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancerM J O'Connell, J Rubin, R G Hahn, et al.
Cancer Research|January 1, 1990
Phase I and clinical pharmacological evaluation of a parenteral hexamethylmelamine formulationM M Ames, R L Richardson, J S Kovach, et al.
Cancer Chemotherapy Reports|May 1, 1975
Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinomaC G Moertel, A J Schutt, R G Hahn, et al.
Cancer Chemotherapy Reports|July 1, 1975
Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinomaT A Marciniak, C G Moertel, A J Schutt, et al.
Cancer|August 1, 1986
The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancerC G Moertel, J R O'Fallon, V L Go, et al.
Pageof 26